Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in Net LoansChange in TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Abvc Biopharma (ABVC) Exchange Rate Effect (2018 - 2025)

Abvc Biopharma (ABVC) has disclosed Exchange Rate Effect for 8 consecutive years, with $12246.0 as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Exchange Rate Effect rose 253.42% year-over-year to $12246.0, compared with a TTM value of $20264.0 through Dec 2025, up 182.41%, and an annual FY2025 reading of $20264.0, up 182.41% over the prior year.
  • Exchange Rate Effect was $12246.0 for Q4 2025 at Abvc Biopharma, down from $51804.0 in the prior quarter.
  • Across five years, Exchange Rate Effect topped out at $322300.0 in Q2 2023 and bottomed at -$308804.0 in Q1 2023.
  • Average Exchange Rate Effect over 5 years is -$4877.9, with a median of -$1595.0 recorded in 2021.
  • The sharpest move saw Exchange Rate Effect tumbled 16389.25% in 2021, then soared 1421.41% in 2025.
  • Year by year, Exchange Rate Effect stood at -$39600.0 in 2021, then soared by 654.14% to $219438.0 in 2022, then crashed by 175.78% to -$166288.0 in 2023, then skyrocketed by 102.08% to $3465.0 in 2024, then surged by 253.42% to $12246.0 in 2025.
  • Business Quant data shows Exchange Rate Effect for ABVC at $12246.0 in Q4 2025, $51804.0 in Q3 2025, and -$50616.0 in Q2 2025.